Lay Review Committee
Great science
isn’t enough
The Lay Review Committee (LRC) helps translate complex, jargon-heavy scientific descriptions into engaging, easy-to-understand website presentations.
The LRC consists of individuals
affected by Type 1 Diabetes.
These members bring a unique perspective, having gained an understanding of the science behind the disease after being confronted with T1D. Our invaluable team simplifies the complex science into clear, accessible language, ensuring that the purpose and goals of each project are clearly understood by all.
Once a project receives approval from the Scientific Review Committee, this core committee collaborates with the researcher to develop a presentation. Members possess a working knowledge of the scientific terminology frequently used in Type 1 Diabetes. The expected time commitment is approximately 6 hours every six months.
If you are interested in serving on the LRC, please email info@DiabetesResearchConnection.org.

Layperson Core
Committee
David Winkler
David has had Type 1 Diabetes for over 60 years and also has several family members and friends with the disease. He is a founder of the Diabetes Research Connection and currently serves as the Chief Financial Officer. David has been a tireless advocate and donor for diabetes research.
Brianna Wolin
Brianna has lived with Type 1 Diabetes for 21 years. Her passion, energy, and optimism for overcoming the challenges of living with and curing T1D are extraordinary and are matched by her drive and intelligence.
She is currently pursuing a double graduate degree, one at Northwestern University in Prosthetics and Orthotics and one at Johns Hopkins in Applied Biomedical Engineering.
Margery Perry
Margery has a daughter with Type 1 Diabetes. Margery is on the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and serves on the Board of Directors of the Breakthrough T1D International.
Bob King
Bob’s daughter was diagnosed with Type 1 Diabetes at age 32. Diabetes Research Connection is his first affiliation.
Amy Adams
Amy Adams served on the Board of Directors for the Juvenile Diabetes Research Foundation (JDRF) for 6 years, served on JDRF’s Chicago Chapter’s Gala, and Walk organizing committees for about 10 years, and is currently a sustaining board member of JDRF.
She also served on the Board of Friends United (a diabetes fundraising organization) for about 3 years and was a contributing writer to Insulin Free Times.
David Winkler
David has had Type 1 Diabetes for over 60 years and also has several family members and friends with the disease. He is a founder of the Diabetes Research Connection and currently serves as the Chief Financial Officer. David has been a tireless advocate and donor for diabetes research.
Brianna Wolin
Brianna has lived with Type 1 Diabetes for 21 years. Her passion, energy, and optimism for overcoming the challenges of living with and curing T1D are extraordinary and are matched by her drive and intelligence.
She is currently pursuing a double graduate degree, one at Northwestern University in Prosthetics and Orthotics and one at Johns Hopkins in Applied Biomedical Engineering.
Margery Perry
Margery has a daughter with Type 1 Diabetes. Margery is on the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and serves on the Board of Directors of the Breakthrough T1D International.
Bob King
Bob’s daughter was diagnosed with Type 1 Diabetes at age 32. Diabetes Research Connection is his first affiliation.
Amy Adams
Amy Adams served on the Board of Directors for the Juvenile Diabetes Research Foundation (JDRF) for 6 years, served on JDRF’s Chicago Chapter’s Gala, and Walk organizing committees for about 10 years, and is currently a sustaining board member of JDRF.
She also served on the Board of Friends United (a diabetes fundraising organization) for about 3 years and was a contributing writer to Insulin Free Times.
David Winkler
David has had Type 1 Diabetes for over 60 years and also has several family members and friends with the disease. He is a founder of the Diabetes Research Connection and currently serves as the Chief Financial Officer. David has been a tireless advocate and donor for diabetes research.
Brianna Wolin
Brianna has lived with Type 1 Diabetes for 21 years. Her passion, energy, and optimism for overcoming the challenges of living with and curing T1D are extraordinary and are matched by her drive and intelligence.
She is currently pursuing a double graduate degree, one at Northwestern University in Prosthetics and Orthotics and one at Johns Hopkins in Applied Biomedical Engineering.
Margery Perry
Margery has a daughter with Type 1 Diabetes. Margery is on the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and serves on the Board of Directors of the Breakthrough T1D International.
Bob King
Bob’s daughter was diagnosed with Type 1 Diabetes at age 32. Diabetes Research Connection is his first affiliation.
Our Active Research Projects
-
Project # 64: aE-catenin: Gatekeeper of Endocrine cell proliferation & ß-cell Regeneration
Mark AndradeUniversity of Washington -
Project #63: The role of PD-L1 in beta cell extracellular vesicles in type-1 diabetes
Chaitra Rao, Ph.DIndiana University -
Project #62: LGR4-ECD: A potential therapeutic for type 1 diabetes-related beta cell stress
Joanna Filipowska, Ph.D.City of Hope -
Project #59: Determine the role of viral infections and viral-insulin carrying viruses in T1D pathogenesis
Aurelien Chuard, Ph.D.Boston College -
Project #60: GPER, inflammation and diabetic kidney disease
Carmen De Miguel, Ph.D.University of Alabama at Birmingham -
Project #57: Precision genetics for type 1 diabetes prevention
Kristen Lavelle, MDUniversity of California, San Francisco -
Project #71: A synthetic biological glucose sensing and regulating system for blood glucose control
Eric Petersen, PhDCentral Michigan University -
Project #69: Role of miR-192 in the derivation of pancreatic islet tissue from pluripotent stem cells
Chrystal GuzmanUniversity of Washington School of Medicine -
Project #70: Combined inhibition of RANKL/RANK and DYRK1A pathways for T1D therapy
Nagesha Guthalu Kondegowda, Ph.D.Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope -
Project #68: Direct reprogramming pancreatic ductal cells into insulin-producing cells by controlling the epigenome using AI-designed mini-protein EpiBinder
Shiri Levy, PhDUniversity of Washington School of Medicine -
Project #66: Investigating the role of risk locus BACH2 rs72928038 in limiting adaptive immune repertoire diversity and promoting effector memory phenotypes in T1D
Leeana Peters, PhDUniversity of Florida -
Project #67: Identifying an autoreactive B-cell signature in at-risk T1D individuals
Lindsay BassVanderbilt University -
Project # 64: aE-catenin: Gatekeeper of Endocrine cell proliferation & ß-cell Regeneration
Mark AndradeUniversity of Washington -
Project #63: The role of PD-L1 in beta cell extracellular vesicles in type-1 diabetes
Chaitra Rao, Ph.DIndiana University -
Project #62: LGR4-ECD: A potential therapeutic for type 1 diabetes-related beta cell stress
Joanna Filipowska, Ph.D.City of Hope -
Project #59: Determine the role of viral infections and viral-insulin carrying viruses in T1D pathogenesis
Aurelien Chuard, Ph.D.Boston College -
Project #60: GPER, inflammation and diabetic kidney disease
Carmen De Miguel, Ph.D.University of Alabama at Birmingham -
Project #57: Precision genetics for type 1 diabetes prevention
Kristen Lavelle, MDUniversity of California, San Francisco -
Project #71: A synthetic biological glucose sensing and regulating system for blood glucose control
Eric Petersen, PhDCentral Michigan University -
Project #69: Role of miR-192 in the derivation of pancreatic islet tissue from pluripotent stem cells
Chrystal GuzmanUniversity of Washington School of Medicine -
Project #70: Combined inhibition of RANKL/RANK and DYRK1A pathways for T1D therapy
Nagesha Guthalu Kondegowda, Ph.D.Arthur Riggs Diabetes and Metabolism Research Institute, City of Hope -
Project #68: Direct reprogramming pancreatic ductal cells into insulin-producing cells by controlling the epigenome using AI-designed mini-protein EpiBinder
Shiri Levy, PhDUniversity of Washington School of Medicine -
Project #66: Investigating the role of risk locus BACH2 rs72928038 in limiting adaptive immune repertoire diversity and promoting effector memory phenotypes in T1D
Leeana Peters, PhDUniversity of Florida -
Project #67: Identifying an autoreactive B-cell signature in at-risk T1D individuals
Lindsay BassVanderbilt University
We grant up to $75,000 to support each research project
#InnovativeDiabetesResearch